デフォルト表紙
市場調査レポート
商品コード
1701013

フローサイトメトリー市場規模、シェア、成長分析、技術別、製品別、用途別、エンドユーザー別、地域別-2025~2032年産業予測

Flow Cytometry Market Size, Share, Growth Analysis, By Technology, By Product, By Application, By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
フローサイトメトリー市場規模、シェア、成長分析、技術別、製品別、用途別、エンドユーザー別、地域別-2025~2032年産業予測
出版日: 2025年04月02日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

フローサイトメトリーの世界市場規模は2023年に61億米ドルと評価され、2024年の66億9,000万米ドルから2032年には139億2,000万米ドルに成長し、予測期間(2025~2032年)のCAGRは9.6%で成長する展望です。

フローサイトメトリー市場は、がん、免疫疾患、感染症の罹患率の増加により、大きな成長が見込まれています。バイオテクノロジー、ライフサイエンス、バイオ医薬品セグメントへの研究開発投資の増加が、フローサイトメトリー機器の需要を促進しています。ポイントオブケア(POC)検査用のマイクロ流体フローサイトメトリーの出現などの技術の進歩は、これらの機器の分析能力を高めています。例えば、これらの革新的な検査はフローサイトメトリーを利用して、COVID-19抗原に対する患者の反応に関する重要な洞察を提供し、十分な情報に基づいた治療方針の決定を容易にしています。感染症の流行が世界的に増加し続ける中、フローサイトメトリー技術の採用は拡大し、今後数年間の産業の勢いにさらに貢献すると予想されます。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の展望
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と展望

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主要市場の考察

  • 重要成功要因
  • 競合の程度
  • 主要投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 特許分析
  • 規制分析
  • 技術分析
  • 使用事例

フローサイトメトリー市場規模:技術別&CAGR(2025~2032年)

  • 市場概要
  • セルベースのフローサイトメトリー
  • ビーズベースのフローサイトメトリー

フローサイトメトリー市場規模:製品別&CAGR(2025~2032年)

  • 市場概要
  • 試薬と消耗品
    • 抗体
    • アッセイとキット
    • その他の試薬と消耗品
  • 機器
    • 細胞分析装置
    • ハイレンジ細胞分析装置
    • ミッドレンジ細胞分析装置
    • ローレンジ細胞分析装置
    • 細胞選別装置
    • ハイレンジ細胞選別装置
    • ミッドレンジ細胞選別装置
    • ローレンジ細胞選別装置
  • サービス
  • ソフトウェア
  • 付属品

フローサイトメトリー市場規模:用途別&CAGR(2025~2032年)

  • 市場概要
  • 研究用途
    • 製薬・バイオテクノロジー
    • 創薬
    • 幹細胞研究
    • 検査管内毒性検査
    • 免疫学
    • 細胞選別
    • アポトーシス
    • 細胞周期分析
    • 細胞生存率
    • 細胞カウント
    • その他の研究用途
  • 臨床用途
    • がん診断
    • 血液学
    • 自己免疫疾患
    • 臓器移植
    • その他の臨床用途
  • 産業用途

フローサイトメトリー市場規模:エンドユーザー別&CAGR(2025~2032年)

  • 市場概要
  • 学術研究機関
  • 病院と臨床検査室
  • 製薬・バイオテクノロジー企業

フローサイトメトリー市場規模&CAGR(2025~2032年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他のラテンアメリカ
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他の中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主要市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022~2024年)

      主要企業プロファイル

      • Becton, Dickinson, and Company(米国)
      • Danaher Corporation(米国)
      • Thermo Fisher Scientific, Inc.(米国)
      • Agilent Technologies, Inc.(米国)
      • Sony Group Corporation(日本)
      • Bio-Rad Laboratories, Inc.(米国)
      • Miltenyi BIoTec GmbH(ドイツ)
      • Enzo Biochem, Inc.(米国)
      • Sysmex Corporation(日本)
      • bioMErieux S.A.(フランス)
      • Cytonome, LLC(米国)
      • Sartorius AG(ドイツ)
      • Cytek Biosciences, Inc.(米国)
      • Apogee Flow Systems Ltd.(英国)
      • Merck KGaA(ドイツ)
      • Beckman Coulter, Inc.(米国)
      • Stratedigm, Inc.(米国)
      • Nanocellect Biomedical(米国)

結論と提言

目次
Product Code: SQMIG35H2031

Global Flow Cytometry Market size was valued at USD 6.1 billion in 2023 and is poised to grow from USD 6.69 billion in 2024 to USD 13.92 billion by 2032, growing at a CAGR of 9.6% during the forecast period (2025-2032).

The flow cytometry market is poised for significant growth, driven by the increasing incidence of cancer, immune disorders, and infectious diseases. Rising R&D investments in biotechnology, life sciences, and biopharmaceutical sectors are fueling the demand for flow cytometry instruments. Technological advancements, such as the emergence of microfluidic flow cytometry for Point-of-Care (POC) testing, are enhancing the analytical capabilities of these instruments. For instance, these innovative tests utilize flow cytometry to provide critical insights into patients' responses to COVID-19 antigens, facilitating informed treatment decisions. As the prevalence of infectious diseases continues to rise globally, the adoption of flow cytometry techniques is expected to expand, further contributing to industry momentum in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Flow Cytometry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Flow Cytometry Market Segments Analysis

Global Flow Cytometry Market is segmented by Technology, Product, Application, End User and region. Based on Technology, the market is segmented into Cell-Based Flow Cytometry and Bead-Based Flow Cytometry. Based on Product, the market is segmented into Reagents & Consumables, Instruments, Services, Software and Accessories. Based on Application, the market is segmented into Research Applications, Clinical Applications and Industrial Applications. Based on End User, the market is segmented into Academic & Research Institutes, Hospitals & Clinical Testing Laboratories and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Flow Cytometry Market

The rising focus on personalized medicine and targeted therapies is significantly boosting the demand for advanced flow cytometry techniques. Flow cytometry's capability to simultaneously analyze multiple parameters enhances the precise characterization of cells, which is essential in formulating individualized treatment strategies. This technology allows for a deeper understanding of cellular properties and behaviors, making it an invaluable tool in the development of tailored therapeutic approaches. As healthcare increasingly prioritizes personalized treatment options, the role of flow cytometry in accurately assessing and monitoring patient conditions will continue to expand, thereby driving growth in the market.

Restraints in the Flow Cytometry Market

The flow cytometry market faces significant constraints due to the high initial investment and ongoing maintenance costs associated with the equipment. These financial barriers can be a deterrent for many laboratories and institutions, particularly smaller or underfunded facilities that may struggle to allocate sufficient resources for such advanced technology. As a result, the reluctance or inability to invest in flow cytometry can hinder its adoption and integration into various research and clinical settings. Consequently, this financial challenge may limit the overall growth potential of the flow cytometry market, impacting its accessibility and utilization across the healthcare and research sectors.

Market Trends of the Flow Cytometry Market

The flow cytometry market is witnessing a transformative phase, significantly influenced by advancements in cell sorting technologies that enhance the ability to isolate and analyze individual cell populations. This is particularly impactful in critical fields such as cancer research, immunology, and stem cell research, where high purity and accuracy are paramount. The increasing demand for precise cellular analysis in both research and clinical environments is propelling market growth, highlighting the pivotal role of flow cytometry in personalized medicine and targeted therapies. As researchers and clinicians seek innovative solutions to unravel complex cellular behaviors, the flow cytometry market is poised for sustained expansion and innovation.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Patent Analysis
  • Regulatory Analysis
  • Technology Analysis
  • Case Studies

Global Flow Cytometry Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Cell-Based Flow Cytometry
  • Bead-Based Flow Cytometry

Global Flow Cytometry Market Size by Product & Service & CAGR (2025-2032)

  • Market Overview
  • Reagents & Consumables
    • Antibodies
    • Assays & Kits
    • Other Reagents & Consumables
  • Instruments
    • Cell Analyzers
    • High-range cell analyzers
    • Mid-range cell analyzers
    • Low-range cell analyzers
    • Cell Sorters
    • High-range cell sorters
    • Mid-range cell sorters
    • Low-range cell sorters
  • Services
  • Software
  • Accessories

Global Flow Cytometry Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Research Applications
    • Pharmaceutical & Biotechnology
    • Drug Discovery
    • Stem Cell Research
    • In Vitro Toxicity Testing
    • Immunology
    • Cell Sorting
    • Apoptosis
    • Cell Cycle Analysis
    • Cell Viability
    • Cell Counting
    • Other Research Applications
  • Clinical Applications
    • Cancer Diagnostics
    • Hematology
    • Autoimmune Diseases
    • Organ Transplantation
    • Other Clinical Applications
  • Industrial Applications

Global Flow Cytometry Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Academic & Research Institutes
  • Hospitals & Clinical Testing Laboratories
  • Pharmaceutical & Biotechnology Companies

Global Flow Cytometry Market Size & CAGR (2025-2032)

  • North America (Technology, Product & Service, Application, End User)
    • US
    • Canada
  • Europe (Technology, Product & Service, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Technology, Product & Service, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Technology, Product & Service, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Technology, Product & Service, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Becton, Dickinson, and Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sony Group Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Miltenyi Biotec GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Enzo Biochem, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMErieux S.A. (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cytonome, LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cytek Biosciences, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Apogee Flow Systems Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beckman Coulter, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stratedigm, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nanocellect Biomedical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations